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VAN DER ZEE, E. A., R. BENOIT, A. D. STROSBERG AND P. G. M. LUITEN. Coexistence of muscarinic acetylcholine recep- 
tors and somatostatin in nonpyramidal neurons of the rat dorsal hippocampus. BRAIN RES BULL 26(3) 343-351, 1991.-This 
study describes the colocalization of muscarinic ace~i~hoiine r ceptors (mAChRs) and the neuro~ptide somatos~tin (SOM) in 
nonpyramidal neurons of the rat dorsal hippocampus. SOM and mAChRs were identified by i~~ocytffihe~s~ employing anti- 
body S309 and M35, respectively. Half of the SOMergic cell population is found to be immunoreactive for muscarinic receptor 
protein as obtained by fluorescent double-labeling techniques. These findings provide additional evidence for a direct cholinergic 
influence upon SOMergic, nonpyramidal neurons, and defines the anatomical distribution of SOMergic, cholinoceptive neurons in 
the dorsal hip~~pus. Concerning the muscarinic holinoceptive, non~yr~i&l neuron ~pulation of the dorsal hip~~pus, a 
considerable number (approximately one-third) was found to be colocalized with somatostatin. These results indicate that a signifi- 
cant part of the cholinergic influence upon hippocampal nonpyramidal neurons is relayed via SOMergic neurons. 
Double-1abeIing immunocytochemistry 
Dorsal hip~~pus 
Somatostatin Muscarinic acetylcholine r ceptor Rat brain 
COMPLEX neuronal networks within the hippocampus are found 
to be related to learning and memory processes. There is ample 
evidence that the cholinergic septo-hippocampal projection, in- 
nervating all major cell groups of the hippocampus in a regional 
and laminar topography (13, 16, 17, 19, 24, 31, 40), is of sig- 
nificant importance in these functions (8, 23, 34). Muscarinic 
ace~lcholine receptors (mAChRs) are considered to be the pri- 
mary receptors in cholinergic synaptic transmission involved in 
learning and memory (7,lO). Recently, muscarinic holinoceptive 
neurons have been visualized by immunocytochemical methods 
in our laboratory employing the monoclonal antibody M35 raised 
against purified mAChR proteins (50). From these methods, it 
became clear that muscarinic receptor immunocytochemistry pro- 
vides an additional tool for further high resolution receptor study 
at the cellular and subcellular level. 
Somatos~tin (SOM) is one of the most important neuropep- 
tides which interacts with the forebrain cholinergic system. Fur- 
thermore, SOM was found to be involved in a variety of behavioral 
functions including learning and memory (15, 19, 45). A subpop- 
ulation of hippocampal nonpyramidal neurons is somatostatin- 
ergic (SOMergic) in nature and their cellular dis~bution and 
morphology has been studied in detail (25, 27, 28, 33, 39, 52). 
The interplay between the SOMergic and cholinergic system 
is characterized by m~ulato~ effects of SOM on ~C~-~nc- 
tioning (35-37). However, the functional relevance of the inter- 
action between the cholinergic and somatostatinergic system is 
still a matter of debate (22). Both systems how a consistent de- 
cline of activity in Alzheimer’s disease (AD) (6, 14, 20, 44, 48). 
The reported ecrease of activity of both transmitter systems in 
AD coincides with a significant to severe loss of hippocampal 
SOMergic neurons and breakdown of the cholinergic septo-hip- 
pocampal projection (12, 30, 43). 
Presently, it is well established that p~midal neurons and 
granule cells as well as some nonpyramidal neurons receive a 
cholinergic innervation from the medial septum-diagonal band 
complex, and therefore belong to the (muscarinic) cholinoceptive 
system (13, 16, 17, 24). In addition, a subclass of the cholinergi- 
tally innervated nonpyr~d~ neurons in the hilar re.gion of the 
dentate gyms was proven to be SOMergic in nature (27,29). In 
agreement with these observations, we recently demonstrated a 
monosynaptic septal input to SOMergic hippocampal neurons by 
P~use~l~s vulgar-is leuco-agglutinin (PHA-L) tracing (51). These 
tracing methods. however, do not permit a quantitative approach 
of SOMergic neurons receiving a cholinergic input. Also it re- 
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mains unclear which proportion of cholinoceptive neurons is 
SOMergic in nature. In order to define the ratio of neurons being 
both SOMergic and muscarinic cholinoceptive, we therefore stud- 
ied the colocalization of somatostatin and mAChRs employing 
fluorescent immunocytochemical double-labeling techniques. In 
the present study we will demonstrate that about half of the pop- 
ulation of SOMergic, nonpyramidal neurons in the dorsal hippo- 
campus possess mAChRs. Consequently, these SOMergic neurons 
are under influence of cholinergic activity through mAChRs. This 
~pulat~on of double-ladled cells comprises approximately one- 
third of the total number of muscarinic cholin~eptive. nonpyra- 
midal neurons in the dorsal hippocampus. 
TABLE I 
NUMBER OF NEURONS COUNTED AND PERCENTAGE OF 
C‘OLOCALIZATION FOR M35 AND S309 IN THE DORSAL. NIPPOC.AMPUS 
AS OBTAINED FROM FLUORESCENT LABELING 
Region s309 S309 ’ iM3S ’ 1,“; Double Labeled) 
Subiculum 322 154 I-IX, 
CAI-CA3 1020 530 I511 
HilUh 736 362 (4’11 
Total 2078 I o&s 1501 
METHOD 
Five young adult male Wistar rats (300 g body weight) were 
used in this study. Fixation of the brain was carried out by trans- 
cardial perfusion of 300 ml of fixative consisting of 3% para- 
formaldehyde, 0.05% glutaraldehyde and 0.2% picric acid in 0.1 
M phosphate buffer (PB) at pH 7.4. Fixation was preceded by a 
prerinse with 50 ml saline solution at a perfusion speed of 25 ml/ 
min. and followed by 100 ml of 10% sucrose in 0.1 M PB. The 
brains were removed. stored overnight in 30% buffered sucrose 
at 4°C for c~op~tection, and coronally sectioned on a cryostat 
microtome at a thickness of 20 microns. 
Muscarinic acetylcholine receptors (mAChRs) and somatosta- 
tin were visualized by means of monoclonal antibody M35 raised 
against muscarinic receptor protein, and polyclonal antibody S309 
directed against the first 14 amino acids of somatostatin-28, re- 
spectively. Extensive descriptions of production, characterization 
and immunocytochemical application of both antibodies have been 
previously reported (l-3. 5. 9, 38. 50). 
lmmunocytochemical Staining Procedure 
From each rat, M35-single, S309-single, as well as S309iM35 
double-labeling ex~~ments were performed. For single labeling, 
the brain sections were incubated 24 h at 4°C in the primary an- 
tibody solution of phosphate buffered saline (PBS), containing 
mouse IgM anti-mAChR (M35, 1:2000) or rabbit IgG antisoma- 
tostatin (S309, 16000). Prior to both the primary and secondary 
antibody steps, the sections were preincubated in 10% normal 
rabbit serum or normal goat serum for M35 or S309, respec- 
tively. In the case of M35, the primary antibody step was fol- 
lowed by exposure to biotinylated rabbit anti-mouse IgM [Zymed, 
1:200, 2 h at room temperature (RT)] and subsequently to 
streptavidin-HRP (Zymed, 1:200, 2 h at RT). For 5309, the sec- 
tions were incubated with goat anti-rabbit IgG (Zymed, 150, 2 h 
at RT). followed by rabbit-PAP (Dakopatts, 1400. 2 h at RT). 
During all incubation steps of the S309 protocol. 0.5% Triton X- 
100 was added to enhance antibody penetration yielding an opti- 
mal labeling result. Finally, all tissue sections were processed by 
a diamino~nzidine (DAB)-H,O, reaction (30 mg DAB and 0.01% 
HzO,/lOO ml Tris buffer), guided by a visual check, and then 
mounted for light microscopic inspection. 
Double-labeling experiments for the study of coexpression of 
mAChRs and somatostatin in single cells were carried out with 
fluorescent techniques. The sections were exposed to one of the 
primary antibodies as for single labeling described above. S309- 
incubation was followed by phycoerythrin-conjugated goat anti- 
rabbit IgG (Tago, 1:200, 2 h at RT). During all steps of the S309 
protocol, 0.1% Triton X-100 was added to the incubation me- 
dium. This concentration of detergent was found to be the best 
compromise between no Triton X- 100 (optimal condition for M35) 
and 0.5% T&on X-100 (optimal condition for S309). By reduc- 
Single- and double-labeled SOMergic neurons in different areas of the 
dorsai hippocampus as obtained from fluorescent labeling. The percent- 
age of SOMergic neurons colocalized with m4ChRs reached about 50% 
in all hippocampal regions studied. M35’ =M35-immunopositive: 
S309 + = S309-immunopositive. 
ing the amount of detergent o 0.1% as a compromise, the most 
weakly stained SOMergic hippocampal neurons may be over- 
looked in this study [unilaterally counted cells of a single section 
containjng the dorsal hip~campus: 0.5% Triton X- 100: t 12 * 1.2 
(SE): 0.1% Triton X-100: 1021 I .5 (SE)]. Therefore, the propor- 
tion of coexpression found in this study may be slightly over- or 
underestimated. After completion of the S309 staining, the sec- 
tions were incubated with M35. followed by biotinylated rabbit 
anti-mouse IgM and fluorescein isothiocyanate (FIT0conjugated 
streptavidin (Zymed, 1:200, 2 h at RT). 
After immunolabeling the sections were mounted and cover- 
slipped in a 1:l mixture of PBS and glycerin. The sections were 
studied and photographed with a Ploemopak Leitz fluorescent mi- 
croscope with the appropriate filter blocks for FITC and phyco- 
erythrin labels, yielding a green and red fluorescence, respectively. 
In the case of a strong phycoerythrin signal, an additional faint, 
yellowish fluorescence was obtained under FITC filter which 
could easily be distinguished from the green FITC fluorescence. 
Standard control experiments were performed by omission of 
the primary antibody step, or by replacing the primary antibody 
by normal mouse serum or normal goat serum. 
For quantification of the double-labeling experiments, we stud- 
ied four to six sections per animal containing the hippocampus at 
the rostro-caudal level of bregma - 2.8 to - 3.8, according to 
the brain atlas of Paxinos and Watson (41). The hippocampus 
was divided in three regions studied on basis of the major local- 
ization of the SOMergic neurons: 1) subiculum, 2) stratum oriens 
of CAl-CA3 (Comu Ammonis), and 3) the hilar region of the 
dentate gyms. The quantitative data are presented in Table 1. 
RESULTS 
Muscarinic Cholinoceptive Neurons 
M35immunolabeled hippocampal cells were observed to in- 
clude pyramidal, granule and nonpyramidal neurons. Besides neu- 
rons, a minority of astrocytes was found to be M35 immunoreactive 
as well (Fig. lC, 4C). Both cell bodies and dendritic arboriza- 
tions were visualized by the M35 antibody (Fig. I). Several classes 
of M35positive nonpyramidal neurons were observed in the dor- 
sal hippocampus. Strong immunopositive labeling appeared in a 
considerable number of pyramidal basket cells (long axis of the 
soma lo-20 Frn; the size of these neurons averaged 16 Frn) em- 
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FIG. 1. Photomicrographs of M35-immunoreactive n urons in the dorsal hippocampus. (A) Nonpyra~d~ neurons (thick arrows) in the stratum pyra- 
midale am larger and more intensely stained than the surrounding pyramidal cells. (B, C) Some typically nonpyramidal neurons and their dendnitic pro- 
cesses in the subiculum (B) and stratum oriens (C). Thick arrow in (C): a M35-i~unoreactive glial ceil. (Df A sheet of M35-positive neumns in the 
stratum lacunosum-moleculare (thin arrows). (E) Granule cells and their extensive dendritic arborizations in the upper blade of the dentate gyms. (F) 
Two examples of large neurons in the hilar region of the dentate gyms. Scale bar in A,B,C,E.F= 15 pm; in D=!SO pm. Abb~v~~tions here and in 
other figures: Gr: stratum granulare; Hil: Hilar region; LM: stratum lacunosum-moleculare; Mol: stratum moleculare; Or: stratum oriens; Pyr: stratum 
pyramidale; Rad: stratum radiatum. 
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FIG. 2. Photomicrographs of S309-immunoreactive neurons in the dorsal hippocampus. (A) Cluster of relatively small neurons in the plexiform layer ot 
the subiculum. (B) Clustered SOMergic, nonpyramidal neurons in the stratum oriens. (C) Some typical, but rarely observed SOMergic neurons embed- 
ded within the pyramidal cell layer. (D) Some large neurons in the deep hilar region of the dentate gyms. Scale bar= 15 pm. Abbreviations as in 
Fig. I. 
bedded within the CAl-CA3 pyramidal cell layer (Fig. lA, 3A). 
Several forms of M35-positive nonpyramidal neurons were scat- 
tered throughout the subiculum (Fig. lB), stratum oriens/alveus 
(Fig. lC), and stratum lacunosum-moleculare (LM; Fig. 1D) of 
the Comu Ammonis. In these regions, the neurons appeared to be 
medium to large sized (15-30 pm). Most M35-positive neurons 
in the stratum LM had a somewhat spherical or spindle-shaped 
appearance, and were topographically arranged in a characteristic 
row (Fig. lD, small arrows). These LM neurons were shown to 
be immunonegative for somatostatin. 
In the dentate gyms, a heterogeneous population of small (10 
km) to large (30 km) muscarinic cholinoceptive nonpyramidal 
neurons were observed (Fig. 1F). They were distributed through- 
out the polymorphic layer and the hilar region, as well as in the 
molecular layer. A multiform population of midsized to large 
(15-28 km) M35-positive basket cells was found either embed- 
ded in or adjacent o the hilar margin of the granule cell layer 
(Fig. 3C). Most of these neurons had pyramidal or somewhat 
flattened cell bodies and were provided with horizontally oriented 
dendritic processes. Like the linearly arranged neurons in the 
stratum lacunosum-moleculare, the cells embedded in the hilar 
margin of the granule cell layer were immunoreactive for 
M35 only. 
The distribution pattern of muscarinic cholinoceptive nonpyra- 
midal neurons proved to be very consistent in all animals studied. 
In contrast, the degree of M35-immunoreactivity in the main 
cell layers showed some individual as well as some regional 
variation. 
SOMergic Neurons 
The SOM-immunoreactive cell distribution visualized by the 
polyclonal antibody S309 revealed no differences as compared to 
previous findings (25,39), and all SOM-immunopositive neurons 
were of nonpyramidal class. In general the SOM-immunolabeled 
cells were distributed more in clusters (Fig. 2) than the scattered 
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FIG. 3. Pho~micrographs of some types of single-labeled M35- (left panel; A, C) and S309-i~unoreactive neurons (right panel; B, D) to show di- 
rect comparison within the same hippocampal areas. (A-B) Basket-like nonpyramidat neumns situated within the pyramidal cell layer. The muscarinic 
cholinoceptive nonpyramidal neurons (thick arrow in A) are generally larger and more spherical in shape than their S309 counterparts. (C-D) M35- 
immunoreactive basket cells in the hilar region of the granule cell layer (thick arrow in C) were found to be S309-negative. Elongated M35- (C) and 
S309- (D) immunoreactive nonpyramidal neurons just beneath the granule cell layer, displaying striking resemblance in morphology (thin arrow). Scale 
bar= 15 pm. Abbreviations as in Fig. 1. 
M35immunoreactive nonpyramidal neurons. In the dorsal hippo- 
campus, SOM-immunopositive multipolar and spindle-shaped neu- 
rons, including medium-sized (15-20 pm) and large cells (25-30 
pm), were predominantly found in the plexiform layer of the 
subiculum, the CA l-CA3 stratum oriens/alveus and the polymor- 
phic and deep hilar region of the dentate gyms. Some SOh4ergic 
neurons in the stratum oriens showed a clear difference in mor- 
phology as compared to the M35-positive neurons. For example, 
a part of these SOMergic neurons appeared to be bipolar, spher- 
ical cells with thick proximal dendritic processes (Fig. 4D). This 
class of neurons appeared to be devoid of muscarinic acetylcho- 
line receptors. As is the case with M35-positive nonpyramidal 
neurons, some SOMergic cells were found to be localized within 
the CAl-CA3 pyramidal cell layer (Fig. 2C, 3A, B). However, 
they differed in morphology, were less numerous and smaller than 
the M35immunoreactive nonpyramidal neurons, ranging from 7.5 
to 15 pm in size (average 10 pm). Only rarely the largest neu- 
rons of this population appeared to be muscarinic holinoceptive. 
As mentioned above, no SOMergic neurons were found in the 
stratum lacunosum-moleculare. 
SOMergic, Muscarinic Cholinoceptive Neurons 
The partial resemblance in morphology and distribution of the 
two cell populations already indicated a tentative coexpression of 
mAChRs and SOM in some nonpy~~d~ neurons in the three 
hippocampal areas studied. Such a striking resemblance is illus- 
trated in Fig. 3C-D showing a similarly looking M35- and S309- 
immunoreactive nonpyramidal neuron in the hilar region of the 
dentate gyrus (small arrow). Fluorescent double-labeling experi- 
ments affirmed the putative colocalization of these two substances. 
This class of hilar nonp~a~dal neurons hown in Fig. 3C-D just 
beneath the granule cell layer indeed coexpressed mAChRs and 
somatostatin (Fig. 4E-F). Such double-labeled neurons were found 
in all dorsal hippocampal regions containing SOMergic cells, 
Double-labeled as well as single-labeled (single SOMergic or sin- 
gle muscarinic cholinoceptive) nonpyramidal neurons were dis- 
tributed amongst each other in the plexiform layer of the subiculum, 
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FIG. 4. Fluorescent photomicrographs depicting double-labeled neurons in the dorsal hippocampus. (A. C. E) Neurons labeled with FITC for M.35: 
iB. D, E) Neurons labeled with phyc~~t~n for S309. The arrows in A to D indicate single labeled nonpyr~jdal neurons in the stratum oriens 
(A-B: M35, C-D: 53091. Adjacent to the SOMergic cell in D, a M35-immunor~active ghat cell in C (asterisk) is present. which is clearly devoid of 
5309 i~unoreact~vity (D). Under FITC filter, the strong phyc~~~rin-labeler SOMergic cell (D) shows a yellowish Iluorescence farrow in C). In 
E-F a ch~cte~stic hi&r nonpyr~dai neuron (arrow) is double Iabeled. This neuron strongly resembles the one shown in Fig. K-D. The smati 
arrows point at transsectioned dendritic processes, which are M35immunopositive only. Scale bar= 10 pm. Abbreviations as in FiF. 1. 
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the CAl-CA3 stratum oriens (Fig. 4A-B, C-D) and the poly- 
morphic and deep hilar region of the dentate gyrus (Fig. 4E-F). 
Moreover, no consistent, discernible morphological differences 
between the cholinoceptive and noncholinoceptive SOMergic 
neuronal subpopulations distinguished in this study were found. 
Per single 20 p_rn section of the dorsal hippocampus, unilater- 
ally cell counts of SOMergic neurons revealed an average of 
102% 1.5 (SE) neurons (numbers ranging from 90-l 10). These 
cell counts showed that half of this SOMergic cell population 
possesses muscarinic acetylcholine receptors. This proportion 
slightly fluctuated in a random fashion for adjacent sections and 
between left and right dorsal hippocampi. Nearly identical pro- 
portions of colocalization were found in the different hippocam- 
pal regions investigated. Furthermore, data pooled per animal 
revealed a consistent coexpression of about 50% in all animals. 
Therefore, average numbers were calculated from collected data 
obtained from all dorsal hippocampi studied (Table 1). 
acid (GABA)ergic cells. Some studies claim that as much as 90% 
of the SOMergic hilar neurons is immunoteactive for GABA 
(26,49). It is concluded that these SOMergic cells serve both 
feed-forward and feed-back inhibitory processes in the dentate 
gyrus (1 I ,29). Furthermore, cholinergic afferents to GABAergic 
hilar basket cells are implicated in feed-forward inhibition (28,29). 
Taken together, the SOMergic muscarinic cholinoceptive neurons 
found in this study are likely candidates for inhibitory processes 
driven by the excitatory cholinergic septal input. 
Cell counts per 20 pm sections obtained from DAB-processed 
hippocampal sections revealed an average of 114 [ + 1.3 (SE)] 
and 153 [ -t 1.1 (SE)] neurons immunopositive for S309 and M35, 
respectively. Since half of the SOMergic neurons are muscarinic 
cholinoceptive, they in turn made up about one-third of the total 
number of M35-immunoreactive nonpyramidal neurons in the 
hippocampus at the rostro-caudal evel studied. 
Besides a cholinergic influence upon SOMergic neurons through 
mAChRs as discussed above, a more direct interplay between 
somatostatin and mAChRs is reported by Miyoshi and co-work- 
ers (35-37). In tissue homogenates, somatostatin, acting through 
its own receptors, reduces the affinity of the agonist binding of 
the Ml mAChR-subtype in the hippocampus, thereby affecting 
the synaptic transmission of acetylcholine. In this way, an inhib- 
itory modulatory effect on cholinergic hippocampal activity is 
suggested. 
Finally, the (muscarinic) cholinoceptive principal and SOM- 
ergic intemeurons are simultaneously innervated by the septal 
cholinergic neurons (13, 16, 17, 24). The functional implication 
of a combined release of somatostatin and acetylcholine upon tar- 
get cells will vary, depending on the quantity and temporal con- 
text (32). 
DISCUSSION 
The results presented here demonstrated half of the SOMergic 
hippocampal cell population to be immunoreactive for muscarinic 
receptor protein. As such, these findings provide additional evi- 
dence for a direct cholinergic influence upon SOMergic, nonpy- 
ramidal neurons, and define the anatomical distribution of 
SOMergic, cholinoceptive neurons in the dorsal hippocampus. 
Concerning the muscarinic cholinoceptive, nonpyramidal neuron 
population of the dorsal hippocampus, a considerable number 
(approximately one-third) was found to be colocalized with soma- 
tostatin. These results indicate that a significant part of the 
cholinergic influence upon hippocampal nonpyramidal neurons is 
relayed via SOMergic neurons. 
Research on neurotransmitter deficits in Alzheimer’s disease 
(AD) showed a consistent decrease in cholinergic and somato- 
statinergic activity (6, 12, 14, 20, 44, 8). However, the precise 
mechanisms of interaction between both systems remain unclear. 
SOMergic immunoreactivity is not influenced by cholinergic den- 
ervation of the rat hippocampus (42), and long-term cholinergic 
denervation of the cortex was even shown to induce a significant 
increase of SOM immunoreactivity (18). Nevertheless, it is ten- 
tative to speculate on a crucial role of the SOMergic muscarinic 
cholinoceptive neurons as a morphological substrate involved in 
learning and memory function of the hippocampus. Future re- 
search may further elucidate possible differences in vulnerability 
of the two SOMergic cell populations as distinguished in this 
study, in AD. 
An interaction between the cholinergic and somatostatinergic 
systems has also been reported for the cerebral cortex and the 
striatum. Somatostatin was released in an atropine-sensitive man- 
ner after acetylcholine application to cultured cerebral cortical 
neurons, suggesting involvement of mAChRs (46). Striatal mus- 
carinic acetylcholine receptors were also found to be associated 
with SOMergic neurons (4). In agreement with these studies, we 
found SOMergic neurons both in the cerebral cortex and striatum 
to be colocalized with mAChRs in our double-labeling experi- 
ments (data not shown). 
In conclusion, half of all dorsal SOMergic hippocampal neu- 
rons belong to the muscarinic cholinoceptive cell population. The 
SOMergic muscarinic cholinoceptive cell group is randomly dis- 
tributed between the entire SOMergic cell population throughout 
the dorsal hippocampus, and includes approximately one-third of 
the total muscarinic cholinoceptive nonpyramidal neurons. No 
characteristic laminar or regional organization was observed in 
relation to its SOMergic nonmuscarinic cholinoceptive counter- 
part. Future research may elucidate the possibility of the two dif- 
ferent SOMergic subpopulations found in this study to be 
functionally distinct groups of neurons. 
A functional implication of the cholinergic influence upon 
SOMergic hippocampal neurons may lie in feed-forward and 
feed-back inhibitory processes. The SOMergic neurons are con- 
sidered to be a subpopulation of inhibitory gamma-aminobutyric 
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